New Breast Cancer TreatmentProvides information on the MammoSite Radiation Therapy System for breast cancer.Medical Update
About a third of breast cancer survivors are still living with fatigue and reduced exercise capacity after treatment ends. The field of breast cancer research is rapidly evolving, with more efficacious treatment options than ever before. However, many survivors are still facing long-term adverse ...
WASHINGTON, Jan. 13 (Xinhua) -- The U.S. Food and Drug Administration (FDA) has expanded the approved use of a drug to treat certain types of breast cancer that have spread and whose tumors have a specific inherited genetic mutation. It is the first time any drug has been approved to ...
Breast cancer, affecting primarily women, is one of the most common cancers with increasing survival rates, yet treatment remains an area for improvement.1As of 2019, female breast cancer has the highest rates of new diagnoses and is the second highest in number of cancer-related deaths in wome...
In 20 to 30% ofbreast cancer patients, the over-expression of a particular protein (human epidermal growth factor-2) is the main cause of the proliferation ofcancer cells. Over the past few yearsHerceptin® (trastuzumab) has become the standard treatment for this kind of cancer. While it ...
New treatments for breast cancer: Breakthroughs for patient care or just steps in the right direction? Three areas of clinical research in breast cancer treatment led to news breaking presentations at the American Society of Clinical Oncology (ASCO) meeting,... A Goldhirsch,AS Coates,M Castiglione...
New Treatment Regimen Shows Promise for Bladder Cancer Patients However, double pursestring suture (DPS) shows promise in the treatment of nipple excision. This study aimed to investigate the safety and aesthetic ... C Nalley - 《Oncology Times》 被引量: 0发表: 2023年 New Combination Shows Ear...
Both immunotherapies and targeted therapies are showing significant promise in these areas, offering patients new treatment options.Q: The sub-category of HER2-low has been a major recent development in breast cancer. Why is this category and its identification so important? Danielle Roman, PharmD,...
Findings by Monash Biomedicine Discovery Institute (BDI) researchers have pointed to a new combination of treatments that may help breast cancer patients with certain gene mutations.…
Approximately 10 to 15 percent of breast cancer cases do not respond to treatment with hormone therapy, which means that they are more aggressive and often recur. An international research team led by researchers at Lund University in Sweden has uncovere